OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, July 8th BSRC, XSNX, UOMO, ARTE, ALTI, ADAT

Jul 08, 2008 (M2 PRESSWIRE via COMTEX) -- XSNX | Quote | Chart | News | PowerRating -- Our Stocks to Watch today BioSolar Inc. (OTCBB: BSRC), XsunX Inc. (OTCBB: XSNX), UOMO Media Inc. (OTCBB: UOMO), Artes Medical Inc. (NASDAQ: ARTE), Altair Nanotechnologies Inc. (NASDAQ: ALTI), Authentidate Holding Corp. (NASDAQ: ADAT)

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.

BIOSOLAR INCORPORATED (OTC: BSRC | Quote | Chart | News | PowerRating) "Up 7.60% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

July 7 - Record-High Petroleum Prices a Boon to BioSolar

Company's Cost-Saving Bio-Based Materials for Photovoltaic Solar Modules Poised to Decrease Industry's Oil Dependence

BioSolar, Inc. (OTCBB: BSRC | Quote | Chart | News | PowerRating) reports that surging oil prices have resulted in unprecedented price hikes in photovoltaic solar module manufacturing, creating substantial growth opportunities for BioSolar. The company's breakthrough technology dramatically reduces the cost of solar modules by replacing traditional and expensive petroleum-based components with bio-based materials derived from renewable plant sources. This dramatic pricing differential is expected to accelerate demand for BioSolar's products as manufacturers scramble to control skyrocketing manufacturing and components costs.

"With the plastics industry undergoing price increases of up to 40% for petroleum-based plastics, we believe that the cost savings offered by our BioBacksheet product will accelerate manufacturers' adoption of our product into their photovoltaic modules," said Dr. David Lee, BioSolar's CEO. "The savings will reduce the final cost per watt of solar electricity by allowing manufacturers to lower the cost of their finished product without being impacted by the rising cost of petroleum."

A recent article in PlasticsNews underscores how manufacturers are impacted by price increases of commodity chemicals, as well as "almost unprecedented" run-ups in energy and raw materials costs. The June 22, 2008 article notes that companies are impacted not only by rising raw materials costs, but the associated electricity and transportation costs as well. Kevin Swift, chief economist at the American Chemistry Council, says, "Each $1 increase in the price of a barrel of crude oil costs the chemical industry $660 million annually

For a $1 increase in 1 million BTUs of natural gas, it's $3.3 billion in new costs."

"The market for solar power is already in explosive growth mode, and photovoltaic technology has progressed markedly in recent years with advances making the cells more efficient, lighter and less expensive. But BioSolar is singularly positioned to lead the development of truly sustainable and cost-effective solar technology as the first company to introduce a new dimension of cost reduction by replacing petroleum-based plastic solar cell module components with durable non-food, bio-based materials," said Lee.

BioSolar is in the process of transitioning into full-scale production of its BioBacksheet in a 60,000-square-foot state-of-the-art facility operated by its contract manufacturing partner, Rowland Technologies, Inc.

By incorporating Rowland Technologies' world-class manufacturing capabilities with BioSolar's unique material engineering, BioSolar is producing an environmentally-friendly product with characteristics that exceed the thermal index requirements of solar module manufacturers.

"We expect this breakthrough product to be rapidly accepted as the standard for the backsheet component of both traditional and certain thin-film photovoltaic modules," said Lee.

XSUNX INCORPORATED (OTCBB: XSNX)

Detailed Quote: http://www.otcpicks.com/quotes/XSNX.php

Company Profile: http://www.otcpicks.com/xsunx/xsunx.htm

Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.

XSNX News:

July 8 - XsunX, Inc. Announces Upcoming Shareholder Conference Call

XsunX Inc. (OTCBB: XSNX), a solar technology company engaged in the build-out of its multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facilities, announced the scheduling of an open line Q&A conference call on Thursday, July 10, 2008 from 1-2 p.m. Pacific (4-5 p.m. Eastern) for the investment community to call in and discuss with XsunX executive management the topics of the shareholder letter released June 24, 2008 - including the company's efforts to establish its TFPV manufacturing presence.

Conference Call

To participate in the call, please dial in to the toll free number, up to fifteen minutes prior to the scheduled start time.

The dial-in number is 1-866-394-7480, conference ID number: 54867296

For more information about XsunX and to view the shareholder letter, visit www.xsunx.com.

UOMO MEDIA INCORPORATED (OTCBB: UOMO | Quote | Chart | News | PowerRating) "Up 9.47% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/UOMO.php

UOMO Media Inc. is a multi-channel entertainment company that acquires, produces, and manages intellectual media content and digital assets. UOMO integrates existing and well-established revenue streams in recorded music, publishing, talent management and distribution through its four operating divisions: UOMO Digital Distribution, UOMO Recorded Music, UOMO Talent Management, and UOMO Publishing.

UOMO News:

July 8 - UOMO Media Announces Revenues

UOMO Media Inc. (OTCBB: UOMO), a multi-channel entertainment and media company, announced that in the first two months of the first quarter of the new fiscal year, the company has experienced (unaudited) revenues.

The company noted that while there has been an economic downturn of late, the numbers would seem to point to a turn-around when it comes to the opportunity of monetizing entertainment assets. The International Federation of the Phonographic Industry (IFPI) estimated that the broader music industry was worth approximately US$130 billion in 2006.

PriceWaterhouseCoopers estimates that by 2011, the global media and entertainment industry will be worth US$ 2 trillion.

The Company's CFO, Ms. Jueane Thiessen commented, "The revenues from the launch of our new operations have exceeded management's internal expectations and our numbers seem to demonstrate that we are moving into revenues faster than we originally anticipated."

Mr. Camara Alford, CEO and Chairman of UOMO Media, added, "This further confirms our business model. With our vision of how we can develop the current market opportunities, we expect that we will only continue to increase our revenues across our entertainment-based media properties."

The company notes that the numbers contained in this release are unaudited, and are made in good faith and based on all the financial information available to the company at present.

ARTES MEDICAL INCORPORATED (NASDAQ: ARTE | Quote | Chart | News | PowerRating) "Up 26.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ARTE.php

Artes Medical, Inc., a medical technology company, focuses on the developing, manufacturing, and commercializing injectable aesthetic products for the dermatology and plastic surgery markets in the United States. It offers ArteFill, a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds. The company also provides individual skin test kits. Artes Medical markets and sells ArteFill to dermatologists, plastic surgeons, and cosmetic surgeons through its direct sales force. The company, formerly Artes Medical USA, Inc., was founded in 1999 and is headquartered in San Diego, California.

ARTE News:

July 8 - Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler

Artes Medical, Inc. (NASDAQ: ARTE), a medical aesthetics company, announced that it has entered into an exclusive U.S. sales and marketing agreement with Anika Therapeutics Inc. (NASDAQ: ANIK) for Elevess, Anika's proprietary FDA-approved hyaluronic acid (HA) based temporary dermal filler for the correction of facial wrinkles and folds.

Through this agreement, Artes Medical's dedicated sales force will market and sell Elevess, the first FDA-approved HA dermal filler for the temporary correction of facial wrinkles that is formulated with an anesthetic for patient comfort, as well as the company's flagship product, ArteFill, the first and only FDA-approved non-resorbable wrinkle filler for long-lasting correction of smile line wrinkles. As a result, Artes Medical becomes the first and only company in the U.S. with a product portfolio of approved dermal fillers that provide patients with a full range of treatment options.

"Through our agreement with Anika Therapeutics we have broadened our product portfolio for our 42-person sales team enabling us to now provide physicians and patients with more treatment options for wrinkle correction," said Christopher J. Reinhard, Executive Chairman, Artes Medical. "Elevess is ideal for patients seeking immediate, comfortable wrinkle correction that lasts six months or more, and ArteFill is the only FDA-approved, non-resorbable treatment for patients desiring long-lasting results. Both products are excellent stand-alone treatment options for wrinkle correction. In addition, they may also be bundled for sequential use. Elevess may be used for initial correction during the ArteFill skin test waiting period, to be followed by an ArteFill long-lasting treatment. Based on this, we will be introducing a new plan that provides favorable economic incentives for both physicians and patients when ArteFill and Elevess are used in concert with each other. With these products, Artes Medical is now uniquely positioned to deliver a full spectrum of wrinkle treatments for the growing facial aesthetics market."

Under the terms of the agreement, Anika Therapeutics will manufacture Elevess and supply Artes Medical with a fully packaged product. Artes Medical will be responsible for the marketing and sale of Elevess to dermatologists, plastic surgeons and cosmetic surgeons in the U.S.

ABOUT ELEVESS

Anika's Elevess is the first FDA approved injectable soft-tissue filler to combine hyaluronic acid (HA) and lidocaine, a local anesthetic that improves patient comfort, and provides physicians with a new alternative for their aesthetic practice. Hyaluronic acid is a naturally occurring polymer found throughout the body and is present in the skin, where it supports skin structure and elasticity. Designed for longer durability based on its proprietary cross-linking technology and its high concentration of Anika's chemically modified hyaluronic acid, Elevess has been approved for sale in the United States, the European Union and Canada.

ABOUT ARTEFILL

ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds. The unique PMMA microspheres in ArteFill are not absorbed by the body and therefore provide the first-of-its-kind support for long-lasting wrinkle correction.

An ArteFill Skin Test is required before initial treatment. The most common adverse events associated with ArteFill treatment, similar to those observed with other dermal fillers, are lumpiness, persistent swelling or redness and increased sensitivity at the injection site.

ArteFill is a proprietary formulation comprised of polymethylmethacrylate, or PMMA, microspheres and bovine collagen, and is the only PMMA-based injectable product that has been approved by the FDA for the treatment of facial wrinkles. Artes Medical is the sole manufacturer of ArteFill, which is only available in the United States through Artes Medical, and Artes Medical has not entered into distribution or licensing arrangements with any third party for the distribution or sale of ArteFill, or any other PMMA-based dermal filler, outside the United States.

ALTAIR NANOTECHNOLOGIES INCORPORATED (NASDAQ: ALTI | Quote | Chart | News | PowerRating) "Up 28.47% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ALTI.php

Altairnano is an innovator and supplier of advanced novel, ceramic nanomaterials. A seasoned management team with substantial experience in commercializing innovative, disruptive technologies, complements Altairnano's leading edge scientists. The company has developed nanomaterials for the alternative energy, life sciences and performance materials markets based on its proprietary manufacturing process. This process also provides the foundation for its innovative AHP pigment process. Altairnano is a leading manufacturer of advanced battery pack systems, which are used in stationary power applications, and electric and hybrid-electric vehicles. For more information, visit www.altairnano.com.

ALTI News:

July 8 - Altair Nanotechnologies Announces Successful Grid Interconnection and Operation of Two-Megawatt Battery System

Grid-Scale Validation Expected to Open New Markets in the Utility Sector for Altair's Battery Technology Altair Nanotechnologies Inc. (NASDAQ: ALTI), a leading manufacturer of safe, high-performance lithium-titanate battery and energy storage products, announced the successful completion of a demonstration and validation program for a two-megawatt 500 kilowatt-hour battery system purchased by AES Corporation (NYSE: AES).

The program was developed and validated by KEMA, Inc. and executed by AES personnel and subcontractors. KEMA's testing showed the battery system successfully met the program's milestones, which was conducted to demonstrate the applicability of Altair's large platform technology to frequency regulation, a key service currently provided by power plants to the electric grid. This demonstration also suggests that the technology could be used for several other utility applications.

"The positive AES results validate the immense opportunities in the utility sector," said Terry Copeland, President and CEO for Altair Nanotechnologies. "Our patented lithium titanate battery technology represents a significant advancement in frequency regulation and can provide utilities and generating companies with a valuable tool and resource in the growing challenge of grid management."

"We are pleased with the results of the Altairnano units. This two megawatt validation project is one of the final steps in our move towards commercial deployment of grid-scale energy storage," said Chris Shelton, Director of Energy Storage Development at AES. "Fast-responding, high-efficiency energy storage systems such as these will create a more resilient grid and allow for increased use of variable generating sources such as wind and solar."

The two-megawatt battery system was installed and operated at a substation owned by Indianapolis Power & Light (IPL), an AES company. The system contained two one-megawatt battery storage units each consisting of one Altairnano 250 kilowatt-hour lithium titanate battery stack, AC-to-DC power conversion system, HVAC units, a control system and transformers to connect to the IPL grid. During the validation exercise the capacity of each unit was tested by repeatedly charging and discharging at one megawatt for 15 minutes. In a second test, two megawatts of power from each of the units were used to show the capability of paralleling two separate systems. Additional testing included simulated frequency regulation, which involved switching the units from charge to discharge at up to one megawatt of power every four seconds for several hours. The KEMA summary report will be available on Altair's website at www.altairnano.com and on the KEMA website at www.kema.com.

In August 2007 AES Corporation and Altair Nanotechnologies announced a joint development and equipment purchase agreement. Under the terms of the agreement, the companies will develop a suite of energy storage solutions. This first solution is a modular unit designed to deliver in excess of one megawatt of power and 250 kilowatt-hours of energy per unit. Multiple units can be linked together in systems to provide both more power and more energy storage.

Altair and AES are working together toward utilization of these systems to provide more efficient management of energy quality, frequency control, and real-time energy fluctuations in milliseconds at grid level. The battery systems' extended cycle-life, high-efficiency, and power profile for the continuous delivery of pulses of plus or minus one megawatt to the grid differentiate Altair's battery storage system from other potential solutions in the marketplace.

ABOUT THE AES CORPORATION

AES is one of the world's largest global power companies, with 2007 revenues of $13.6 billion. With operations in 29 countries on five continents, AES's generation and distribution facilities have the capacity to serve 100 million people worldwide. AES's 15 regulated utilities amass annual sales of over 78,000 GWh, and their 123 generation facilities have the capacity to generate more than 43,000 megawatts. The AES global workforce of 28,000 people is committed to operational excellence and meeting the world's growing power needs. To learn more about AES, visit www.aes.com or contact AES media relations at media@aes.com.

AUTHENTIDATE HOLDINGS CORPORATION (NASDAQ: ADAT | Quote | Chart | News | PowerRating) "Up 36.36% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ADAT.php

Authentidate Holding Corp., through its subsidiaries, provides software applications and Web-based services that enable enterprises and individuals to exchange the electronic content transaction securely. Its offerings incorporate security technologies, such as electronic signing, identity management, and content authentication to electronically facilitate secure and trusted transactions. The company's products include Inscrybe Healthcare, a secure Web-based information network that enables users in the healthcare industry to exchange information via the Web or fax; and Inscrybe Office, a Web-based service, which enables to sign, seal, and confirm receipt of important documents over the Web. It also provides signature-based business process software applications and solutions. In addition, Authentidate Holding Corp. is developing Inscrybe platform that incorporates the use of the U.S. Postal Service Electronic Postmark. The company sells its software and Web-based services primarily through direct sales and resellers. It operates in the United States and Germany. The company was founded in 1985 as Bitwise Designs, Inc. and changed its name to Authentidate Holding Corp. in 2001. Authentidate Holding Corp. is headquartered in Berkeley Heights, New Jersey.

ADAT News:

July 8 - ExpressMD Signs Non-Exclusive Distribution Agreement with Cyntrist to Deliver Remote Patient Monitoring and Telehealth Systems to Healthcare Providers in the Southeastern U.S.

Cyntrist to Utilize ExpressMD Solutions' Telehealth System to Improve Diabetic Care

ExpressMD Solutions, a joint venture formed by Authentidate Holding Corp. (NASDAQ: ADAT | Quote | Chart | News | PowerRating) and EncounterCare Solutions, Inc. (OTC: ESCL) to provide remote patient monitoring telehealth systems and services that improve care for patients, has signed its first user contract and distribution agreement with Cyntrist, a comprehensive diabetic care company headquartered in Central Florida. Cyntrist will distribute Express MD's systems and services throughout the Southeastern U.S. region. Initially Cyntrist will target Alabama, Florida, Georgia, North Carolina, and South Carolina.

ExpressMD Solutions' systems and services enable unattended measurement of a patient's vital signs and related health information. This patient data is securely sent over the Internet to the patient's healthcare provider for review.

Cyntrist will utilize ExpressMD's remote patient monitoring systems and telehealth services to monitor patients diagnosed with Diabetes. Patients will be able to use Electronic House Call(TM) equipped monitoring devices located in their home to record personal health data, including glucose levels and weight. ExpressMD Solutions' service will transmit the data to each patient's care provider as it is collected. By remotely receiving patient data daily, care providers can adjust treatment accordingly and provide an enhanced level of care. In addition, ExpressMD's solution reduces the need for regular office visits, reducing the cost of care.

"Cyntrist's decision to incorporate ExpressMD Solutions' remote patient monitoring telehealth system and services as part of its patient care capabilities, underscores the benefits that telehealth monitoring systems offer patients and healthcare providers," said Ronald Mills, Managing Director at ExpressMD Solutions. "As a way to improve patient care and reduce costs, telehealth systems have the power to change the landscape of patient monitoring. We believe our solution is ahead of the curve in this market and will be widely accepted by meeting a number of monitoring applications going forward."

In June 2008 the Centers for Disease Control and Prevention (CDC) reported that nearly 24 million Americans have diabetes (8% of the population), an increase of more than three million in approximately two years.

"By combining our world-class proprietary Diabetes information management system, Enhanced Diabetes Information System (EDIS(TM)), with ExpressMD Solutions' remote patient monitoring telehealth system, we are introducing a capability that goes above and beyond what is currently available for treating patients with Diabetes. A core advantage of this system is that it is easy for patients to use and is cost effective compared to monitoring patients multiple times per week in person. This is a very exciting opportunity for patients, providers and heath insurers," said Rogers Kirven, President of Cyntrist.

ABOUT EXPRESSMD SOLUTIONS

ExpressMD(TM) Solutions is a joint venture formed by Authentidate Holding Corp. (Nasdaq: ADAT - News) and EncounterCare Solutions, Inc. (OTC PK: ECSL). ExpressMD combines EncounterCare's Electronic House Call(TM) patient vital signs monitoring appliances with a specially designed web-based management and monitoring software module based on Authentidate's Inscrybe(TM) Healthcare platform. The company will provide in-home patient vital signs monitoring systems and services to improve care for patients with chronic illnesses and reduce cost of care by delivering results to their healthcare providers securely via the Internet. The ExpressMD solution is designed to aid wellness and preventative care, and deliver better continuity of care to specific patient segments such as the elderly, special needs or pediatric patients with chronic illnesses who require regular monitoring of serious medical conditions. For more information about ExpressMD Solutions, visit www.expressmdsolutions.com.

ABOUT CYNTRIST

Cyntrist is a comprehensive diabetes care company, headquartered in Altamonte Springs, Florida, whose "patient-centric" focus encourages, enables and supports the patient using a "Diabetes Team" approach to achieve improved health outcomes through its proprietary Enhanced Diabetes Information System (EDIS(TM)). Cyntrist's Enhanced Care Programs are targeted to anyone with diabetes who is motivated, or can be motivated, to develop improved self-care skills, and to those who support the person with diabetes. For more information about Cyntrist, visit www.cyntrist.com.

ABOUT ENCOUNTERCARE SOLUTIONS, INC.

EncounterCare Solutions, Inc. (OTC PK: ECSL), headquartered in Palm Beach Gardens, Florida is an integrated healthcare company that operates its business through two divisions, the Healthcare Technology Division and the Healthcare Services Division. EncounterCare's operating businesses offer a broad range of proprietary healthcare technology, products and services that address several substantial target markets, including: the Healthcare Information Technology market, the Healthcare Telemedicine market and the Homecare market. For more information, visit www.encountercare.com.

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks is receiving nine thousand dollars by a third party (BlueWave Advisors) for BSRC advertising and promotion services. OTCPicks.com is being compensated nine thousand dollars by a third party for XSNX advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by a third party (Haynes Capital) for UOMO advertising and promotional services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure-details.htm. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index